● CATEGORY · OTHER156 PROFILES · INDEXED
The other.
156 peptide profiles with mechanisms, dosing protocols, research summaries, and safety data.
Novel and emerging research peptides.
SHOWING · 61–68 OF 68 · OTHER · PAGE 4 OF 4
68 profiles
061
Dermorphin
H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 · Frog Skin Opioid Peptide
Other
Dermorphin is a heptapeptide (7 amino acids) isolated from the skin of Phyllomedusa South American tree frogs.
Research Only
→
062
Endothelin-1
ET-1 · Big Endothelin-1 · Preproendothelin-1 (mature)
Other
Endothelin-1 (ET-1) is a 21-amino acid peptide produced primarily by vascular endothelial cells and is the most potent endogenous vasoconstrictor known.
Research Only
→
063
Galanin
GAL · Galanin Neuropeptide · GAL1-29
Other
Galanin is a 29-amino acid neuropeptide (30 AA in humans) widely distributed in the central and peripheral nervous system and GI tract.
Research Only
→
064
Kyotorphin
Tyr-Arg · L-Tyrosyl-L-Arginine · KTP
Other
Kyotorphin (Tyr-Arg) is an endogenous analgesic dipeptide isolated from bovine brain in 1979.
Research Only
→
065
Orforglipron
LY3502970
Weight Loss
Orforglipron (LY3502970) is an oral, once-daily, non-peptide small-molecule GLP-1 receptor agonist developed by Eli Lilly (originally discovered by Chugai Pharmaceutical).
Research Only
→
066
Ovagen
EDL tripeptide · Glu-Asp-Leu · liver bioregulator
Longevity
Ovagen is a synthetic tripeptide bioregulator (Glu-Asp-Leu, EDL) developed by Professor Vladimir Khavinson targeting the liver and gastrointestinal tract.
Research Only
→
067
Survodutide
BI 456906 · BI-456906
Weight Loss
Survodutide (BI 456906) is a dual glucagon receptor (GCGR) and GLP-1 receptor (GLP-1R) agonist developed by Boehringer Ingelheim and Zealand Pharma.
Research Only
→
068
VK2735
VK-2735
Weight Loss
VK2735 is a novel synthetic dual agonist of the GLP-1 and GIP receptors developed by Viking Therapeutics for treatment of obesity and metabolic disorders.
Research Only
→